Chemoinformaics analysis of alpha-amino-beta-hydroxybutyric acid
| Molecular Weight | 119.12 | nRot | 2 |
| Heavy Atom Molecular Weight | 110.048 | nRig | 1 |
| Exact Molecular Weight | 119.058 | nRing | 0 |
| Solubility: LogS | 0.049 | nHRing | 0 |
| Solubility: LogP | -2.015 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 16.1871 |
| nHD | 3 | BPOL | 9.32686 |
| QED | 0.375 |
| Synth | 3.492 |
| Natural Product Likeliness | 0.742 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.268 |
| HIA | 0.012 |
| CACO-2 | -5.161 |
| MDCK | 0.010088 |
| BBB | 0.414 |
| PPB | 0.107634 |
| VDSS | 0.655 |
| FU | 0.916571 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.068 |
| CYP2c19-inh | 0.033 |
| CYP2c19-sub | 0.224 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.071 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.29 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.079 |
| CL | 3.605 |
| T12 | 0.924 |
| hERG | 0.039 |
| Ames | 0.014 |
| ROA | 0.022 |
| SkinSen | 0.458 |
| Carcinogencity | 0.052 |
| EI | 0.063 |
| Respiratory | 0.297 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.929133 |